Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c70cc66c25854f28ea8816284cd8f9e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2008-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1da021e843258ff490c1edd66db504a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96f3edc96b65f56c4e9fce0faf099f4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5e2837faf789d8bad8d928d779f21ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_175d096ac1b8ef9c11a01de4bae8f741 |
publicationDate |
2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-101679520-A |
titleOfInvention |
The huTNFR1 selective antagonist |
abstract |
The present invention relates to the part of a specific specificity in conjunction with human tumor necrosis factor 1 receptor (huTNFR1), this part comprises one or more people source aminoacid sequences of the immunogenic response that can be reduced in part among the mankind, and one or more aminoacid sequences that can selective binding huTNFR1.The invention further relates to the nucleic acid and the pharmaceutical composition that is used for the treatment of the disease relevant of the described part of coding with huTNFR1. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109641958-A |
priorityDate |
2007-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |